Tecan Group AG

SWX-TECN
SIX Swiss Exchange
Healthcare Medical Instruments & Supplies
Global Rank
#5290
Country Rank
#94
Market Cap
2.65 B
Price
208.48
Change (%)
0.12%
Volume
17,606

Tecan Group AG's latest marketcap:

2.65 B

As of 07/26/2025, Tecan Group AG's market capitalization has reached $2.65 B. According to our data, Tecan Group AG is the 5290th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 2.65 B
Revenue (ttm) 1.18 B
Net Income (ttm) 85.13 M
Shares Out 12.73 M
EPS (ttm) 6.66
Forward PE 22.26
Ex-Dividend Date 04/14/2025
Earnings Date 08/12/2025
Market Cap Chart
Data Updated: 07/26/2025

Tecan Group AG's yearly market capitalization.

Tecan Group AG has seen its market value grow from ₣1.26 B to ₣2.11 B since 2014, representing a total increase of 67.61% and an annual compound growth rate (CAGR) of 5.01%.
Date Market Cap(₣) Market Cap(USD) Change (%) Global Rank
07/26/2025 ₣2.11 B $2.65 B -18.95% 5290
12/30/2024 ₣2.6 B $2.86 B -40.8% 4501
12/29/2023 ₣4.39 B $5.21 B -16.39% 2773
12/30/2022 ₣5.25 B $5.68 B -25.45% 2415
12/30/2021 ₣7.04 B $7.72 B 35.77% 2249
12/30/2020 ₣5.19 B $5.86 B 60.71% 2514
12/30/2019 ₣3.23 B $3.33 B 43.76% 3249
12/28/2018 ₣2.24 B $2.29 B -5.04% 3678
12/29/2017 ₣2.36 B $2.42 B 28.93% 4033
12/30/2016 ₣1.83 B $1.8 B -1.81% 4279

Company Profile

Tecan Group AG Overview

Tecan Group AG is a leading provider of laboratory instruments and solutions, serving industries such as biopharmaceuticals, forensics, and clinical diagnostics. The company operates globally across Europe, North America, and Asia.

Business Segments

  • Life Sciences Business: Offers liquid handling, automation, microplate readers, washers, software, consumables, and end-to-end automation solutions.
  • Partnering Business: Provides contract design, manufacturing services, customized OEM systems, and repair services.

Key Products & Services

  • Liquid handling and automation solutions
  • Microplate readers and washers
  • NGS reagents, immunoassays, and antibodies
  • Tecan Labwerx (end-to-end automation)
  • PARAMIT (contract manufacturing)
  • Synergence (custom OEM systems)
  • Cavro (OEM components)
  • Onsite/depot repairs and remote services

Company Background

Founded in 1980, Tecan Group AG is headquartered in Männedorf, Switzerland, and has established itself as a trusted name in laboratory automation and diagnostics.

Frequently Asked Questions

  • What is Tecan Group AG's (SWX-TECN) current market cap?
    As of 07/26/2025, Tecan Group AG (including the parent company, if applicable) has an estimated market capitalization of $2.65 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Tecan Group AG global market capitalization ranking is approximately 5290 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.